Role of Presenilins in Capacitative Calcium Entry
About the Research Project
Program
Award Type
Standard
Award Amount
$190,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000002
Acknowledgement
Summary
When the normal intracellular stores of calcium are depleted, a response is triggered inside the cell that leads to the influx of calcium from outside the cell. This process is known as capacitative calcium entry, or CCE. Dr. Tae-Wan Kim has found that mutations in presenilin 1 (PS1) or presenilin 2 (PS2) that cause inherited AD are associated with an impaired CCE response. It has also been found that treating cells with an inhibitor of the CCE response causes an increase in the expression of the protein Ab42. This suggests that the CCE response is coupled with the gamma secretase activity associated with PS1, and that it causes the production of Ab42. Dr. Kim is examining these relationships in more detail to determine whether the reduction of CCE is an early event in AD. He also hopes to determine whether increasing CCE response reduces gamma secretase activity. If it does, this result would raise the possibility that drugs that stimulate CCE could lead to the decreased production of Ab42 and the progression of AD.
Related Grants
Alzheimer's Disease Research
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Mechanisms of Inhibitory Neuron Vulnerability to Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Emiliano Zamponi, PhD
Current Organization
Columbia University
Alzheimer's Disease Research
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Targeting Brain Cell Miscommunication to Restore Memory in Alzheimer’s Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Amira Latif-Hernandez, PhD
Current Organization
Stanford University
Alzheimer's Disease Research
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University
Progranulin as a Potential Therapeutic Target for Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2027
Principal Investigator
Andrew Nguyen, PhD
Current Organization
Saint Louis University